Preventing infection transmission has been a chief concern of healthcare leaders and staff striving to protect their patients and themselves from SARS-CoV-2, the virus that causes COVID-19. The virus poses an insidious threat that includes the possibility of bronchoscopy-associated transmission of COVID-19. Long before the pandemic, epidemiologist and researcher Cori…
Editor's Note This study led by researchers at the Massachusetts General Hospital and Harvard Medical School, Boston, finds that patients who survive serious COVID-19 infections have a long-lasting immune response against the virus. The study includes a cohort of case patients with known COVID-19 infection (343) and controls (1,548). Blood…
Editor's Note In this double-blind, randomized, placebo-controlled study of IV remdesivir in adults hospitalized with COVID-19 and lower respiratory tract infection, remdesivir was found to be superior to placebo in shortening the time to recovery. A total of 1,062 patients were randomized to either remdesivir (541) or placebo (521). Remdesivir…
Editor's Note New research presented October 12 at UEG [United European Gastroenterology] Week Virtual 2020 shows that delays in colorectal cancer (CRC) screening caused by COVID-19 has resulted in significantly increased mortality rates. Researchers at the University of Bologna, Italy, developed a model to forecast the impact of delayed CRC…
Editor's Note Leandro Pecchia, PhD, associate professor of biomedical engineering at the University of Warwick, Coventry, UK, has been awarded £13 million (nearly $17 million) for the ODIN project. The project will explore the use of robots and artificial intelligence (AI) to ease pressures on hospitals during recovery from COVID-19…
Editor's Note In this study, researchers from the University of Bristol in the UK, find that intubation and extubation of patients during general anesthesia may produce only a fraction of the aerosols previously thought, much less than that produced during a regular cough. The researchers conducted real-time, high-resolution environmental monitoring…
Editor's Note Preliminary findings in Moderna’s (Cambridge, Massachusetts) COVID-19 trial show the vaccine elicits strong immune system responses in older adults similar to responses in younger recipients, and adverse events associated with the vaccine are mainly mild or moderate. In its expansion to include older adults, the trial enrolled 40…
Editor's Note This study presented September 24 at the European Society of Clinical Microbiology and Infectious Diseases Conference on Coronavirus Disease finds that the initial SARS-CoV-2 viral load (VL) in nasopharyngeal samples has been decreasing as the pandemic progresses. The researchers from Wayne State University/Detroit Medical Center, Detroit, Michigan, also…
Editor's Note In this study from Germany, researchers found that the SARS-CoV-2 virus is highly susceptible to irradiation with ultraviolet (UV) light. High viral loads (5x106TCID50/mL) were inactivated in 9 minutes with UVC (254 nm) irradiation. The UVC dose required for complete inactivation was 1,048 mJ/cm2. Exposure to UVA (365…
Editor's Note ECRI on September 22 released an analysis showing that 60% to 70% of N95 masks from China do not meet US standards for filtration and effectiveness. ECRI tested nearly 200 masks, reflecting 15 different manufacturer models, which have been purchased by large US healthcare systems. ECRI recommends not…